Hexagon Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Hexagon Capital Partners's AMGN Position: Q2 2026 in Review
Hexagon Capital Partners increased its Amgen (AMGN) stake by 12% in Q2 2026, buying an estimated $46.9K and bringing the position to 1,308 shares worth $474K. The position accounts for 0.07% of the portfolio, ranked #144.
Hexagon Capital Partners first reported a position in AMGN in Q3 2020 and has held it in 21 quarters since. The position peaked at $894K in Q2 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Hexagon Capital Partners held 1,308 shares of Amgen worth $474K as of Q2 2026.
- Hexagon Capital Partners bought 137 Amgen shares in Q2 2026, an estimated $46.9K.
- Amgen made up 0.07% of Hexagon Capital Partners's portfolio in Q2 2026, its #144 holding.
- Hexagon Capital Partners first reported a position in Amgen in Q3 2020 and has held it in 21 quarters since.
- Hexagon Capital Partners's Amgen position peaked at $894K in Q2 2024.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Hexagon Capital Partners's 13F filing for Q2 2026, filed 7 Aug 2026.